Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.3.0.814
Consolidated Balance Sheets - USD ($)
Dec. 31, 2014
Dec. 31, 2013
Current Assets    
Cash and cash equivalents $ 4,220,225 $ 3,672,877
Marketable securities 0 15,731
Restricted cash 325,181 555,008
Accounts receivable - project revenue and reimbursable project costs 469,086 425,916
Prepaid expenses and other current assets 205,185 288,939
Total Current Assets 5,219,677 4,958,471
Property Plant and Equipment -net 0 0
Other Assets    
Patent costs 833,560 699,168
Total Assets 6,053,237 5,657,639
Current Liabilities    
Accounts payable and accrued liabilities 653,669 476,628
Total Current Liabilities 653,669 476,628
Warrant liability 4,633,312 1,711,331
Total Liabilities $ 5,286,981 $ 2,187,959
Commitments and contingencies
Stockholders' Equity    
Preferred stock, $0.001 par value, 50,000,000 authorized shares, no shares issued and outstanding $ 0 $ 0
Common stock, $0.001 par value, 500,000,000 authorized, 18,082,874 shares outstanding and 15,057,243 shares outstanding at December 31, 2014 and December 31, 2013, respectively 18,083 15,057
Additional paid-in capital 70,801,464 69,853,600
Accumulated Deficit (70,053,291) (66,398,977)
Total Stockholders' Equity 766,256 3,469,680
Total Liabilities and Stockholders' Equity $ 6,053,237 $ 5,657,639